Innovations Reshape Facial Aesthetics: From Orthodontics to Non-Invasive Treatments

The field of facial aesthetics is experiencing a surge of innovation, with new technologies and treatment strategies emerging to address a range of concerns, from orthodontic alignment to age-related facial changes. Recent developments highlight a move towards more sophisticated, personalized, and less invasive approaches.

Advancements in Orthodontic Aesthetics

Smartee Denti-Technology recently hosted a clinical conference in London, focusing on its Mandibular Advancement Repositioning Technology (MART) for treating Class II malocclusion. This innovative approach offers a non-invasive alternative to extractions or surgery, aiming to improve both function and facial convexity. The conference introduced a new diagnostic classification system that prioritizes facial morphology, categorizing malocclusion into facial convexity, concavity, mandibular deviation, and straight facial profile. This etiology-driven framework helps clinicians target the root cause of discrepancies for more effective treatment strategies.

Non-Invasive Facial Rejuvenation Technologies

Several new technologies are revolutionizing non-invasive facial rejuvenation. Lumenis Be has launched triLift in Canada, a device utilizing Dynamic Muscle Stimulation (DMSt™) alongside RF and RF microneedling. This treatment targets facial muscles, which play a crucial role in facial structure and aging, to achieve a naturally lifted look, reduce wrinkles, and tighten the jawline without surgery or injectables. The multi-layered approach addresses muscle, skin, and volume in a single, quick treatment.

Similarly, BTL has introduced EMFACE, a hands-free device that simultaneously treats facial skin and muscles using synchronized radiofrequency and HIFES™ energies. In just 20-minute sessions, EMFACE aims to reduce wrinkles, increase facial muscle tone, and provide a lifting effect, all without needles or downtime. Clinical studies suggest significant improvements in these areas.

Expanding Dermal Filler Options

In the realm of injectables, Evolus is expanding its hyaluronic acid (HA) dermal filler portfolio. The company has submitted Evolysse Sculpt for FDA approval, a new HA gel designed to restore volume in the mid-facial region. Utilizing a unique Cold-X technology, Evolysse Sculpt aims for natural-looking and longer-lasting results. This submission follows the FDA approval and commercial launch of Evolysse Form and Evolysse Smooth, which have demonstrated impressive safety and efficacy in clinical trials, offering practitioners versatility for precise, natural-looking outcomes.

Key Takeaways

• Holistic Facial Approach: Treatments are increasingly addressing multiple facial layers, including muscles, skin, and underlying structure.

• Minimally Invasive Focus: A significant trend is the development of non-surgical and non-injectable options for facial rejuvenation and alignment.

• Personalized Treatment Strategies: New diagnostic tools and technologies allow for more tailored and effective treatment plans.

• Technological Integration: Combining different energy-based modalities and advanced materials is driving innovation in aesthetic outcomes.

Sources

• Smartee Advances Facial Convexity Treatment Strategy, Dentistry Today.

• triLift By Lumenis Receives Medical Device License from Health Canada, Launches in Canada, PR Newswire.

• Evolus Submits Evolysse Sculpt for FDA Approval, Expanding HA Dermal Filler Portfolio, Dermatology Times.

• BTL REVOLUTIONIZES FACIAL AESTHETICS CATEGORY WITH THE RELEASE OF EMFACE, PR Newswire.